Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer.
Cappuzzo F, Novello S, De Marinis F, Franciosi V, Maur M, Ceribelli A, Lorusso V, Barbieri F, Castaldini L, Crucitta E, Marini L, Bartolini S, Scagliotti GV, Crinò L.
Cappuzzo F, et al. Among authors: crino l.
Br J Cancer. 2005 Jul 11;93(1):29-34. doi: 10.1038/sj.bjc.6602667.
Br J Cancer. 2005.
PMID: 15956971
Free PMC article.
Clinical Trial.